Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

Class:Id	LiteratureReference:5223019
_displayName	Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
_timestamp	2014-01-03 22:02:37
author	[Person:5223030] Ko, Myunggon [Person:5221042] Huang, Yun [Person:5223020] Jankowska, Anna M [Person:5223044] Pape, Utz J [Person:5221035] Tahiliani, Mamta [Person:5223036] Bandukwala, Hozefa S [Person:5223013] An, Jungeun [Person:5223041] Lamperti, Edward D [Person:5221009] Koh, Kian Peng [Person:5223026] Ganetzky, Rebecca [Person:2247957] Liu, X Shirley [Person:69402] Aravind, L [Person:5220969] Agarwal, Suneet [Person:5221071] Maciejewski, Jaroslaw P [Person:2685301] Rao, Anjana
created	[InstanceEdit:5223014] May, B, 2014-01-03
journal	Nature
pages	839-43
pubMedIdentifier	21057493
title	Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
volume	468
year	2010
(literatureReference)	[Reaction:5220944] Tet1,2,3 oxidizes 5-methylcytosine to 5-hydroxymethylcytosine [Mus musculus] [Reaction:5221014] TET1,2,3 oxidizes 5-methylcytosine to 5-hydroxymethylcytosine [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 (5223019)